Samrat Pharmachem Q2 Results

  • BSE: 530125
  • NSE: -
  • ISIN: INE103E01016
  • Sector: Biotechnology & Drugs
BSE
45312.05 (2.73%)
Volume3.69 K
Updated: Mon 25 Nov, 2024 | 15:26:49
NSE
This stock is not traded on NSE
Today: 440.00
462.00
52-Wk: 320.00
646.00

Q2 Results Highlights

  • Total Income
    ₹70.17 Cr.
    (-13.18%)
  • Operating Profit
    ₹3.19 Cr.
    (31.75%)
  • Profit After Tax
    ₹2.66 Cr.
    (28.86%)
  • Operating Margin
    4.55%
    (5174.10%)
Note: Comparison is on YoY basis

Quarterly - Samrat Pharmachem Q2 Results

*All figures in crores except per share values
Fiscal PeriodSep 24Jun 23QoQ CompSep 23YoY Comp
Total Revenue 70.1757.48-%79.74-%
Selling/ General/ Admin Expenses Total 0.500.49-%0.51-%
Depreciation/ Amortization 0.170.16-%0.16-%
Other Operating Expenses Total 1.731.48-%1.81-%
Total Operating Expense 66.9856.87-%79.68-%
Operating Income 3.190.61-%0.07-%
Net Income Before Taxes 3.520.75-%0.24-%
Net Income 2.660.61-%-0.19-%
Diluted Normalized EPS 8.611.98-%-0.61-%

Recommended For You

    More Recommendations

    Trending Stocks

      Subscribe to Our Newsletter

      Get daily newsletters around different themes from livemint.

      Subscribe
      HomeMarketsPremiumInstant LoanMint Shorts